06/12/26 05:02:00
Printable Page
06/12 05:00 CDT Tarik Skubal, the Cleveland Browns and other athletes credit a
tiny new scope for faster recoveries
Tarik Skubal, the Cleveland Browns and other athletes credit a tiny new scope
for faster recoveries
By JAY COHEN
AP Baseball Writer
CHICAGO (AP) --- Several top pro athletes and their surgeons say a modern
version of an old tool is shaving weeks off the recovery time for certain
injuries. And some top doctors think this is only the beginning.
Cy Young Award winners Tarik Skubal and Blake Snell let doctors use the
instrument on their prized elbows. Connor Hellebuyck, the 2025 Hart Trophy
winner as NHL MVP, trusted it to address issues in his knee. Several NFL
players have turned to it, too.
It's called the NanoNeedle scope 2.0, a miniaturized, flexible version of the
traditional arthroscope. It's very early --- there is little published research
on the model --- but it is accumulating an impressive list of proponents.
"Every time I've used it, including when I started using it in the lab,
different types of procedures occur to me that we could do," said Dr. Neal
ElAttrache, the head team physician for the Los Angeles Dodgers and Los Angeles
Rams.
An arthroscope is a pencil-like tube with a camera that goes into joints,
expands the area with salt water or saline, and projects an image onto a
screen. Then doctors insert secondary instruments in the same area to perform
the surgical procedure.
With the diminished size --- 1.9 millimeters in diameter, compared to 4
millimeters for a traditional scope --- the NanoNeedle is designed to cause
less pain, inflammation and tissue damage, leading to a faster recovery. It
uses much less fluid than a traditional scope, and it also is proving to be a
valuable tool when it comes to diagnosing the extent of certain injuries.
"Basically, we're able to accomplish anatomic type of work and repair with far
less surgical trauma," ElAttrache said.
Star athletes have returned ahead of schedule after NanoNeedle procedures
The NanoNeedle was used when Skubal had a loose body removed from his left
elbow by ElAttrache on May 6, and again when Snell had a similar elbow surgery
on May 19.
When Skubal --- a two-time AL Cy Young Award winner who is eligible for free
agency after this season --- was placed on the injured list, the Detroit Tigers
said the ace would be sidelined for two to three months. But he is expected to
return on Saturday after pitching five scoreless innings in a rehab start on
Sunday --- a turnaround of about 5 1/2 weeks.
ElAttrache said he has used the NanoNeedle scope with four patients, but he
declined to identify the other two cases. Snell had a bigger operation that
also involved the sculpting of a spur, but ElAttrache is optimistic about the
timeline for the left-hander's return to the Dodgers.
"The percentage of time out, I think, is going to be about half the time for
Snell," ElAttrache said.
Hellebuyck, a three-time Vezina Trophy winner as the NHL's top goalie, had
arthroscopic surgery on his right knee on Nov. 22. He was expected to be
sidelined for four to six weeks, but he was back in net for the Winnipeg Jets
after three weeks.
Dr. James Voos, the head team physician for the Cleveland Browns, said he has
used the NanoNeedle during procedures on five Browns players, including center
Luke Wypler's ankle fracture surgery.
"Ankles and elbows I think are areas where it has had very great utility and
then rapidly adopted," said Voos, who also serves as the president of the NFL
Physicians Society. "And we're finding more and more uses in the knee and
shoulder."
In addition to his duties with the Browns, Voos is the chair of the orthopedics
departments at University Hospitals and Case Western Reserve University in
Cleveland. He already has seen benefits when it comes to the treatment of
younger athletes.
"There are some very challenging elbow injuries in gymnasts and baseball
players that the previous cameras were too large for the joint," Voos said.
"They're designed for adult joints. So the smaller camera allows us to see and
work in these smaller spaces. In pediatrics and adolescence, that was more
challenging and potentially caused more damage before, some more soft tissue
damage."
NanoNeedle has been in the works for a few years, and it's still evolving
The NanoNeedle was developed by Arthrex, a Florida-based company that makes
medical supplies. Voos is an educational consultant for Arthrex, and ElAttrache
has worked with the company for more than 30 years.
The initial version was created in 2019, according to Ryan Kellar, a senior
product manager at Arthrex. There was another version that came out in 2023
before the current model --- with upgraded visualization, processing and
imaging --- was released in August.
"This is our third iteration," Kellar said. "We already have the fourth
iteration coming in the fall. That fourth iteration is going to be everything
that this conventional scope is at all the less invasive benefits of nano
arthroscopy. So we really believe that nano is the next foundation of less
invasive orthopedic care for general population, as well as kind of a gold
standard for athletes."
Dr. Kyle Hammond, the head team physician for the Atlanta Falcons and head
orthopedic surgeon for the Atlanta Hawks, has used the NanoNeedle in a teaching
setting as an orthopedic surgeon at Emory Healthcare and assistant professor at
Emory University School of Medicine. But he hasn't used it on a patient yet.
Hammond said other companies have made similar devices for needle arthroscopy,
but he praised the quality of the camera and the video feed with the
NanoNeedle, along with its ease of use.
"It really has basically become very similar to what our standard arthroscopy
equipment is," he said. "It's just on a smaller scale."
The current version of the NanoNeedle is disposable, raising questions about
cost versus the expense of sterilization for the reusable traditional
arthroscope. Like anything in science, Hammond said, more usage and research
are needed to assess the benefits of the new design versus the standard version
of the scope.
"To kind of determine if they have true efficacy over the standard of care,
they have to be used for a long period of time and you have to collect data and
you kind of have to prove that from a statistical model," Hammond said.
Dr. Brian Cole, the head team physician for the Chicago Bulls, said the level
of adoption will depend in large part on the willingness of clinicians to
incorporate the scope into their workflow.
"There's a sort of econometric analysis on top of a healthcare analysis at the
same time," said Cole, who also is a consultant for Arthrex. "But I would say
directionally, this is where we're going. Less invasive, cost-effective,
predictable, eliminating problems that we might or could have with existing
technology. So, in that regard, this is very innovative, you know, in my
opinion, and it's consistent with the direction we're going in."
___
AP sports: https://apnews.com/sports
|